SGA

Sector Gamma AS Portfolio holdings

AUM $306M
This Quarter Return
+4.28%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$447M
AUM Growth
+$447M
Cap. Flow
+$27.5M
Cap. Flow %
6.14%
Top 10 Hldgs %
63.53%
Holding
36
New
5
Increased
15
Reduced
9
Closed
7
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$140B
$46.3M 10.37%
601,367
+58,594
+11% +$4.52M
CAH icon
2
Cardinal Health
CAH
$35.5B
$36.4M 8.14%
384,642
+7,941
+2% +$751K
BMY icon
3
Bristol-Myers Squibb
BMY
$96B
$32.5M 7.26%
507,576
+58,005
+13% +$3.71M
MDT icon
4
Medtronic
MDT
$119B
$30.5M 6.83%
346,508
+27,604
+9% +$2.43M
BIIB icon
5
Biogen
BIIB
$19.4B
$27.3M 6.1%
95,757
+7,921
+9% +$2.26M
INCY icon
6
Incyte
INCY
$16.5B
$24.7M 5.54%
397,532
-34,703
-8% -$2.16M
BDX icon
7
Becton Dickinson
BDX
$55.3B
$24.5M 5.49%
+92,923
New +$24.5M
ZBH icon
8
Zimmer Biomet
ZBH
$21B
$21.7M 4.85%
148,812
-27,291
-15% -$3.97M
BAX icon
9
Baxter International
BAX
$12.7B
$21.6M 4.83%
473,634
+306,634
+184% +$14M
EW icon
10
Edwards Lifesciences
EW
$47.8B
$18.4M 4.12%
195,291
+36,485
+23% +$3.44M
LH icon
11
Labcorp
LH
$23.1B
$17.6M 3.95%
73,104
-8,311
-10% -$2.01M
CNC icon
12
Centene
CNC
$14.3B
$16.5M 3.7%
244,949
+6,203
+3% +$418K
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.2B
$14.1M 3.15%
162,668
+6,318
+4% +$548K
ELV icon
14
Elevance Health
ELV
$71.8B
$13.9M 3.12%
31,351
-4,428
-12% -$1.97M
THC icon
15
Tenet Healthcare
THC
$16.3B
$13.1M 2.94%
161,457
-3,770
-2% -$307K
GEHC icon
16
GE HealthCare
GEHC
$33.7B
$12.3M 2.75%
+151,328
New +$12.3M
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
$11.1M 2.48%
266,370
+32,614
+14% +$1.36M
BRKR icon
18
Bruker
BRKR
$5.16B
$8.3M 1.86%
112,242
-40,875
-27% -$3.02M
CTLT
19
DELISTED
CATALENT, INC.
CTLT
$7.81M 1.75%
180,088
+29,587
+20% +$1.28M
IONS icon
20
Ionis Pharmaceuticals
IONS
$6.79B
$6.58M 1.47%
160,401
+13,960
+10% +$573K
AMED
21
DELISTED
Amedisys
AMED
$6.49M 1.45%
+71,007
New +$6.49M
QGEN icon
22
Qiagen
QGEN
$10.1B
$5.74M 1.28%
127,526
-133,261
-51% -$6M
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$58.5B
$5.33M 1.19%
28,067
+678
+2% +$129K
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.38B
$4.81M 1.08%
200,696
-32,022
-14% -$767K
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$2.89B
$4.64M 1.04%
100,605
-5,677
-5% -$262K